Login to your account

Username *
Password *
Remember Me

RCT: In non–critically ill hospitalized patients with COVID-19, the use of a P2Y12 Inhibitor (ticagrelor in 63% of patients and clopidogrel in 37%) in addition to a therapeutic dose of heparin did not improve survival free of organ support compared to the

Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non–Critically Ill Hospitalized Patients With COVID-19: A Randomized Clinical Trial – JAMA Editorial: Antiplatelet Therapy in Patients With COVID-19—More Is Less? – JAMA Commentary: Adding a P2Y12 Inhibitor Does Not Improve Outcomes in COVID-19 – HealthDay  

The post RCT: In non–critically ill hospitalized patients with COVID-19, the use of a P2Y12 Inhibitor (ticagrelor in 63% of patients and clopidogrel in 37%) in addition to a therapeutic dose of heparin did not improve survival free of organ support compared to therapeutic heparin alone. appeared first on Links Medicus.

COVID-19 testing infographics.

COVID-19 testing infographics – British Society for Immunology   Commentary on Twitter It’s important to understand #COVID19 testing so everyone can make informed decisions about their health ℹ? Our infographics & blog have been updated with the latest information & guidance so you can find out what different tests mean for you ?https://t.co/7a5Ul6tEZn pic.twitter.com/mUzdZc13aa — […]

The post COVID-19 testing infographics. appeared first on Links Medicus.

ASCO Guideline: Management of stage III non–small-cell lung cancer.

Management of Stage III Non–Small-Cell Lung Cancer: ASCO Guideline – Journal of Clinical Oncology  

The post ASCO Guideline: Management of stage III non–small-cell lung cancer. appeared first on Links Medicus.

Case series of Thrombosis with Thrombocytopenia Syndrome after Covid-19 vaccination in the US.

Case Series of Thrombosis With Thrombocytopenia Syndrome After COVID-19 Vaccination—United States, December 2020 to August 2021 – Annals of Internal Medicine Editorial: The Epidemiology of Thrombosis With Thrombocytopenia Syndrome: Analogies With Heparin-Induced Thrombocytopenia – Annals of Internal Medicine  

The post Case series of Thrombosis with Thrombocytopenia Syndrome after Covid-19 vaccination in the US. appeared first on Links Medicus.

Time to upgrade from cloth and surgical masks to respirators? Your questions answered.

Time to upgrade from cloth and surgical masks to respirators? Your questions answered – The Conversation See also: The CDC updated its mask guidelines. What to know about ‘the highest level of protection’ – CNN Related: CDC urges Americans to wear most-protective mask or respirator that fits well and that they’ll wear consistently.  

The post Time to upgrade from cloth and surgical masks to respirators? Your questions answered. appeared first on Links Medicus.

Study raises doubts about rapid Covid tests’ reliability in early days after infection.

Study raises doubts about rapid Covid tests’ reliability in early days after infection – STAT Original Article (preprint): Discordant SARS-CoV-2 PCR and Rapid Antigen Test Results When Infectious: A December 2021 Occupational Case Series – medRxiv  

The post Study raises doubts about rapid Covid tests’ reliability in early days after infection. appeared first on Links Medicus.

COVID-19 updated evidence: a Cochrane round-up.

COVID-19 evidence: a Cochrane round-up – Cochrane Library  

The post COVID-19 updated evidence: a Cochrane round-up. appeared first on Links Medicus.

[Not published yet] Study in Israel finds fourth COVID booster has limited efficacy.

Israel Finds Fourth COVID Booster is Ineffective, While Hospitalised Omicron Patients Fare Much Better Than Delta Patients – Health Policy Watch See also: Israeli trial, world’s first, finds 4th dose ‘not good enough’ against Omicron – The Times of Israel Israel study: 4th vaccine shows limited results with omicron – MedicalXpress  

The post [Not published yet] Study in Israel finds fourth COVID booster has limited efficacy. appeared first on Links Medicus.

Viewpoint: COVID-19 therapeutics for nonhospitalized patients.

COVID-19 Therapeutics for Nonhospitalized Patients – JAMA Editorial: Realizing the Potential of Anti–SARS-CoV-2 Monoclonal Antibodies for COVID-19 Management – JAMA  

The post Viewpoint: COVID-19 therapeutics for nonhospitalized patients. appeared first on Links Medicus.

WHO recommends two new drugs (Baricitinib and Sotrovimab) to treat COVID-19.

News release: WHO recommends two new drugs to treat COVID-19 – World Health Organization Infographic with the updated recommendations: A living WHO guideline on drugs for covid-19 – The BMJ Commentaries: WHO Recommends Two New COVID-19 Treatments – Cost and Availability Likely Barriers – Health Policy Watch Expert reaction to WHO recommending two drugs, sotrovimab […]

The post WHO recommends two new drugs (Baricitinib and Sotrovimab) to treat COVID-19. appeared first on Links Medicus.